Antibiotics Crisis Prompts Rethink On Risks, Rewards
The rapid approval of J&J's tuberculosis drug in December, based only on mid-stage Phase II data, may be a sign of a new
antibiotics crisis prompts rethink risks reward rapid approval jj tuberculosis drug december base mid stage phase ii datum sign new